Dagohoy, Baby Boy 1 .
HRN: 22-39-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
AMPICILLIN 250MG (VIAL)
02/14/2023
02/21/2023
IV
110mg
Q12hours
T/c Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes